
Acyclovir is effective against herpes simplex virus (HSV) type 1 and type 2, varicella zoster virus (VZV) and Epstein-Barr virus (EBV). Acyclovir is taken up by the virus infected cell, converted to acyclovir triphosphate (by viral thymidine kinase) and this inhibits viral DNA synthesis by inhibiting viral DNA polyme rases and causing DNA chain termination. Like acyclovir, valaciclovir, ganciclovir, valganciclovir, famciclovir, penciclovir and idoxuridine get converted to their respective monophosphate, diphosphate and then triphosphate derivatives which are the active metabolites. The active metabolite inhibits viral DNA/RNA polymerases and interferes with viral replication [1].
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
